DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-83 Cr | ₹-42 Cr | ₹-37 Cr | ₹-33 Cr | ₹-27 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR LAL PATHLABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-83 Cr |
| Mar2024 | ₹-42 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-33 Cr |
| Mar2021 | ₹-27 Cr |
How is Deferred Tax Assets / Liabilities of DR LAL PATHLABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-83 Cr | Negative | |
| Mar2024 | ₹-42 Cr | Negative | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-33 Cr | Negative | |
| Mar2021 | ₹-27 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,516.8 Cr | 0% | 3.6% | 5.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹110,701.0 Cr | 2.5% | 2% | 10.6% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹97,990.8 Cr | 5.6% | 1.7% | -11.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹67,172.4 Cr | 5% | 6% | 33.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,307.1 Cr | 4.1% | 9.4% | 5% | Stock Analytics | |
| GLOBAL HEALTH | ₹29,286.1 Cr | 2.3% | 1.7% | -11% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 0% |
3.6% |
5.9% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses